AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

FENNEC PHARMACEUTICALS INC. Director's Dealing 2009

Jul 17, 2009

35599_dirs_2009-07-17_61d609b8-ebfc-46f7-8ea6-02e490eea154.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2009-07-07

Reporting Person: Raykov Rosty (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000000	Direct